Neurogene Inc. (NGNE) Return on equity 2018–2025
Neurogene Inc. (NGNE) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-34.1%FY2025 · since FY2018: -43.5% → -34.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -34.1% | -9.9 pp |
| FY2024 | -24.2% | -4.7 pp |
| FY2023 | -19.5% | — |
| FY2018 | -43.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More NGNE financial trends
NGNE RevenueNGNE Net incomeNGNE Net marginNGNE Gross profitNGNE Gross marginNGNE Operating incomeNGNE Operating marginNGNE Operating cash flowNGNE Free cash flowNGNE Capital expendituresNGNE Stock buybacksNGNE Dividends paidNGNE Total assetsNGNE Total liabilitiesNGNE Shareholders’ equityNGNE overview →